Aeras Appoints Dr. M. M. Sharma to Board of Directors.BETHESDA, Md. -- The Aeras Global TB Vaccine Foundation, a public-private partnership dedicated to developing new vaccines against tuberculosis, announced the appointment of Dr. Man Mohan Sharma Mann Mohan Sharma (born May 1, 1937 in Jodhpur, Rajasthan) is an eminent Indian chemical engineer. He was educated at Jodhpur, Mumbai and Cambridge. At the age of 27 years, he was appointed Professor of Chemical Engineering in the University of Mumbai, Department of Chemical of Mumbai, India, to the Aeras Board of Directors. An eminent chemical engineer, Dr. Sharma is Emeritus Professor of Eminence at the Mumbai University Institute of Chemical Technology Chief Distinctions The number of research articles published per faculty member of UICT is greater than any other research institute in the world. In 2003, UICT was awarded the Indian Mercantile Chamber (IMC) Bajaj Quality Award. Headed by the renowned engineer Prof. J. B. . "We are honored to have Dr. Sharma join the Aeras Board of Directors," said Board Chairman R. Gordon Douglas. "He brings a profound understanding of industrial processes that will greatly assist Aeras in the coming years. He will make an outstanding addition to our Board." Dr. Sharma was the leading teacher and practitioner of chemical engineering in India for a generation. His many students are leaders in chemical engineering and other scientific disciplines in India and around the world. "I am pleased to join the Aeras Board of Directors and contribute to developing a new vaccine against TB," said Dr. Sharma. "India leads the world in number of TB cases, with 3 million people diagnosed with the disease. A new vaccine offers the best hope of controlling TB in India and around the world." Aeras collaborates with leading TB researchers around the world to develop promising candidate vaccines. Currently Aeras has one candidate vaccine in a Phase I trial, two candidates in advanced preclinical stages of development, and several candidates in earlier stages of development. "Dr. Sharma brings not only great expertise but also a developing country perspective that will be invaluable to Aeras as we move candidate TB vaccines into clinical trials in the field," said Aeras President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Jerald C. Sadoff. Aeras recently established a clinical trial site in southern India for testing new TB vaccines. Dr. Sharma was professor of chemical engineering at Mumbai University Institute of Chemical Technology for over three decades and Director of MUICT from 1989 to 1997. He currently serves as Chairman, Research Council, National Chemical Laboratory in Pune, India. He has served as Chairman of the Scientific Advisory Committee of the Indian Ministry of Petroleum and Natural Gas, and has held numerous other leadership positions on scientific committees and editorial boards over the course of his distinguished career. The President of India The President of India (Hindi: Rashtrapati) is the head of state and first citizen of India and the Supreme Commander of the Indian armed forces. In theory, the President possesses considerable power. presented Dr. Sharma with the prestigious Padma Bhushan and Padma Vibhushan awards in 1987 and 2001, respectively. He became a Fellow of the Indian National Science Academy The Indian National Science Academy (INSA) is the apex body of Indian scientists representing all branches of science & technology. The Indian National Science Academy promotes science and its use in India. in 1976, served as Vice President of the Academy in 1987-88, and as President in 1989-90. He received the Academy's Vishwakarma Medal in 1985 and the Meghnad Saha Medal in 1994, and delivered the Sir J.C. Bose Memorial Lecture in 1994. He is a Fellow of the Royal Society Fellow of the Royal Society is an honour accorded to distinguished scientists and a category of membership of the Royal Society. Fellows are entitled to put the letters FRS after their name. Up to 44 new fellows are elected each year by ballot of the existing fellows. , London, which awarded him the Leverhulme Medal in 1996. He was recently elected as an International Fellow of the Royal Academy of Engineering The Royal Academy of Engineering is a British learned society concerned with engineering. History Founded in 1976, the Academy was initially known as the Fellowship of Engineering. , UK. He has published over 250 research papers and authored two books. About Aeras The Aeras Global TB Vaccine Foundation (www.aeras.org) is a non-profit public-private partnership dedicated to developing new tuberculosis vaccines and ensuring their availability to all who need them. Aeras received a grant of US$82.9 million from the Bill & Melinda Gates Foundation for TB vaccine development in February 2004. Development of a clinical trial site in Andhra Pradesh, India, is supported by the U.S. Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center. . Aeras is led by President & CEO Jerald C. Sadoff, MD. Dr. Sadoff has previously overseen FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. licensure of five vaccines and worked on the research and development of numerous other candidate vaccines while at Merck and the Walter Reed Army Institute of Research This article is about the U.S. Army medical research institute (not the hospital). Otherwise, see Walter Reed (disambiguation). The Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion